The future of the global glucometer market looks promising with opportunities in the institutional sales, hospitals, clinics, retail sales, hospital pharmacies, retail pharmacies, and online pharmacies markets. The global glucometer market is expected to reach an estimated $30.5 billion by 2030 with a CAGR of 8.9% from 2024 to 2030. The major drivers for this market are increasing prevalence of diabetes worldwide and rising costs for healthcare infrastructure and increased knowledge of diabetes management.
Some of the Key Questions answered in this exclusive report are:
Q.1. What are some of the most promising, high-growth opportunities for the glucometer market by product (continuous glucose monitoring devices and self-monitoring blood glucose systems), technique (invasive and non-invasive), type (wearable and non-wearable), distribution channel (institutional sales, hospitals, clinics, retail sales, hospital pharmacies, retail pharmacies, online pharmacies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
Market Segmentation:
In this market, continuous glucose monitoring devices and self-monitoring blood glucose systems are the major segments of glucometer market by product. Lucintel forecasts that self-monitoring blood glucose systems will remain the largest segment over the forecast period due to easier to use and affordable.
Within this market, hospital pharmacies will remain the largest segment due to convenience to healthcare professionals.
North America will remain the largest region over the forecast period due to high prevalence of diabetes in the region.
Thermo Fisher Scientific, Promega Corporation, Agilent Technologies, Bio-Rad Laboratories, Qiagen, Merck, B.D., Sanofi, Ascensia Diabetes Care Holdings, and Abbott are the major suppliers in the glucometer market.